Arkolith/Insider Trading/AVTE/Form 4

Eldridge George A

SEE REMARKSAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$390K
Net Open-Market Flow
-$390K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)12K$2.14$27K14K
Apr 1, 2024Sell(S)12K$31.23$390K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)12K—$016K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-010136) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML